Medcolcanna Organics Inc. (MCCNF) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Medcolcanna Organics Inc. (MCCNF) trades at $0.0633 with AI Score 44/100 (Grade C). Medcolcanna Organics Inc. is a medical cannabis company operating in Colombia and Switzerland. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 18, 2026Analyst Coverage for MCCNF: MCCNF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MCCNF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
MCCNF: 1/3 scored disciplines lean bearish. Dominant signal: Izzy Englander bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Medcolcanna Organics Inc. (MCCNF) Healthcare & Pipeline Overview
Medcolcanna Organics Inc. cultivates, produces, and distributes medicinal cannabis and cannabis-derived products in Colombia and Switzerland. The company focuses on pharmaceutical, cosmetic, and bulk API products, positioning itself within the specialty and generic drug manufacturing segment of the healthcare sector, facing competition from other cannabis companies.
What Is the Investment Thesis for MCCNF?
Medcolcanna Organics Inc. presents a high-risk, high-reward investment opportunity within the burgeoning medical cannabis market. The company's focus on both pharmaceutical and cosmetic applications provides diversification, while its operations in Colombia and Switzerland offer access to different regulatory environments. However, negative profitability metrics, including a P/E ratio of -0.06, a profit margin of -7685.8%, and a gross margin of -900.2%, raise concerns about financial sustainability. Key catalysts include potential regulatory changes in target markets and successful product launches. Investors should closely monitor the company's ability to improve its financial performance and capitalize on growth opportunities in the evolving cannabis market. The company's beta of 1.15 suggests higher volatility compared to the overall market.
Based on FMP financials and quantitative analysis
MCCNF Key Highlights
P/E ratio of -0.06 indicates the company is currently not profitable.
- Profit Margin of -7685.8% reflects significant losses relative to revenue.
- Gross Margin of -900.2% suggests the cost of goods sold is substantially higher than revenue.
- Beta of 1.15 indicates the stock is more volatile than the market average.
- The company operates in Colombia and Switzerland, providing geographic diversification.
Who Are MCCNF's Competitors?
MCCNF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BCBCF The BC Bud Corporation | $0.04 | -3.31% | $5.98M | 56 |
| CLSH CLS Holdings USA, Inc. | $0.04 | +0.00% | $5.94M | 43 |
| ZTS Zoetis Inc. | $75.44 | -1.62% | $31.6B | 85 |
| ITCI ITCI | $131.87 | +0.00% | $14.1B | 63 |
| ESALF Eisai Co., Ltd. | $29.90 | +0.00% | $8.44B | 61 |
| LNTH Lantheus Holdings, Inc. | $100.24 | -0.24% | $6.53B | 88 |
| AMRX Amneal Pharmaceuticals, Inc. | $17.90 | -1.16% | $5.72B | 65 |
| CAMRF Camurus AB (publ) | $64.00 | +0.00% | $3.81B | 63 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MCCNF's Key Strengths?
Operations in Colombia and Switzerland.
- Vertical integration.
- Diverse product portfolio.
- Expertise in cannabis cultivation.
What Are MCCNF's Weaknesses?
Negative profitability metrics.
- Reliance on evolving regulations.
- Limited brand recognition.
- Small market share.
What Could Drive MCCNF Stock Higher?
Potential regulatory changes in key markets could expand market access.
- Successful product launches of new cannabis-based pharmaceuticals.
- Expansion of production capacity to meet growing demand.
- Strategic partnerships with pharmaceutical companies.
- Increasing consumer acceptance of medical cannabis.
What Are the Key Risks for MCCNF?
Evolving regulations could restrict market access.
- Intense competition from established players.
- Price volatility in the cannabis market.
- Negative public perception of cannabis.
- Financial losses and negative cash flow.
What Are the Growth Opportunities for MCCNF?
- Expansion into new therapeutic areas: Medcolcanna can explore opportunities to develop cannabis-based treatments for conditions beyond its current focus. The market for cannabis-based pharmaceuticals is expanding, with potential applications in pain management, epilepsy, and other therapeutic areas. Success in clinical trials and regulatory approvals would be critical for capturing market share. This expansion could significantly increase revenue streams over the next 3-5 years as new products are commercialized.
- Geographic expansion: Medcolcanna can extend its operations to new countries with favorable regulatory environments for medical cannabis. Europe and Latin America offer attractive markets with growing demand. Strategic partnerships and acquisitions can facilitate entry into these markets. Expanding its geographic footprint would diversify revenue sources and reduce reliance on its existing markets. This expansion could occur within the next 2-3 years, depending on regulatory developments.
- Development of new cosmetic products: The market for cannabis-infused cosmetic products is growing rapidly, driven by consumer interest in natural and organic ingredients. Medcolcanna can leverage its existing cannabis cultivation and processing capabilities to develop innovative cosmetic products. Successful product launches and marketing campaigns would be essential for capturing market share. This development could see new product lines within the next 1-2 years.
- Strategic partnerships with pharmaceutical companies: Collaborating with established pharmaceutical companies can provide Medcolcanna with access to expertise, resources, and distribution networks. These partnerships can accelerate the development and commercialization of cannabis-based pharmaceuticals. Successful partnerships could lead to significant revenue growth and market expansion. These partnerships could materialize within the next 1-3 years.
- Increased focus on bulk API production: Medcolcanna can capitalize on the growing demand for high-quality cannabis-derived APIs from pharmaceutical and cosmetic companies. Expanding its API production capacity and securing contracts with major players in these industries would drive revenue growth. This focus could establish Medcolcanna as a key supplier in the global cannabis market. This expansion could be implemented within the next 2 years.
What Are MCCNF's Competitive Advantages?
- Geographic diversification with operations in Colombia and Switzerland.
- Vertical integration from cultivation to finished products.
- Focus on both pharmaceutical and cosmetic applications.
- Expertise in cannabis cultivation and processing.
What Does MCCNF Do?
Medcolcanna Organics Inc., based in Calgary, Canada, operates as a medical cannabis company with a focus on cultivation, production, and distribution in Colombia and Switzerland. The company's operations span the entire value chain, from cultivation to the creation of finished products. Medcolcanna's product portfolio includes medicinal cannabis, cannabis-derived pharmaceuticals, cosmetic products, and bulk Active Pharmaceutical Ingredients (API). The company aims to serve both the medical and cosmetic markets with its cannabis-based offerings. Its geographic focus on Colombia and Switzerland allows it to leverage potentially favorable regulatory environments and access international markets. Medcolcanna competes with other cannabis companies in the specialty and generic drug manufacturing space, striving to establish a strong presence in the global medical cannabis market. The company's success hinges on its ability to navigate regulatory complexities, maintain product quality, and effectively market its diverse product range.
What Products and Services Does MCCNF Offer?
- Cultivates medical cannabis in Colombia.
- Produces medicinal cannabis products.
- Distributes medicinal cannabis products in Colombia and Switzerland.
- Develops cannabis-derived pharmaceutical products.
- Creates cannabis-infused cosmetic products.
- Manufactures bulk Active Pharmaceutical Ingredients (APIs) from cannabis.
- Sells products to pharmaceutical companies.
- Sells products to cosmetic companies.
How Does MCCNF Make Money?
- Cultivation and processing of cannabis.
- Manufacturing of cannabis-derived products.
- Sales of products to pharmaceutical companies.
- Sales of products to cosmetic companies.
- Distribution of products in Colombia and Switzerland.
What Industry Does MCCNF Operate In?
Medcolcanna Organics Inc. operates within the rapidly evolving medical cannabis industry. This sector is characterized by increasing acceptance of cannabis for medical purposes, driving demand for cannabis-derived products. The competitive landscape includes established pharmaceutical companies, as well as smaller, specialized cannabis producers. Medcolcanna's focus on both pharmaceutical and cosmetic applications differentiates it from some competitors. The industry is subject to evolving regulations, which can significantly impact market access and growth.
Who Are MCCNF's Key Customers?
- Pharmaceutical companies seeking cannabis-derived APIs.
- Cosmetic companies seeking cannabis-derived ingredients.
- Patients seeking medical cannabis products.
- Consumers seeking cannabis-infused cosmetic products.
Company Profile
Medcolcanna Organics Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Calgary, CA. The company is led by CEO Felipe De La Vega. MCCNF has traded publicly since 2021.
MCCNF Valuation & Market Position
Relative to its peer group, MCCNF's quantitative score of 44/100 is below the peer average of 62/100.
MCCNF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Operations in Colombia and Switzerland.
- Vertical integration.
- Diverse product portfolio.
- Expertise in cannabis cultivation.
Bear Case
- Negative profitability metrics.
- Reliance on evolving regulations.
- Limited brand recognition.
- Small market share.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
MCCNF Latest News
No recent news available for MCCNF.
MCCNF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MCCNF.
Price Targets
Wall Street price target analysis for MCCNF.
MCCNF MoonshotScore
What does this score mean?
The MoonshotScore rates MCCNF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Felipe De La Vega
CEO
Felipe De La Vega is the CEO of Medcolcanna Organics Inc. His background includes experience in managing and scaling businesses within emerging markets. He has a strong understanding of the regulatory landscape and market dynamics in both Colombia and Switzerland. His expertise lies in developing and executing growth strategies, building strategic partnerships, and driving operational efficiency. He is responsible for leading the company's overall vision and strategic direction.
Track Record: Under Felipe De La Vega's leadership, Medcolcanna Organics Inc. has expanded its operations in Colombia and Switzerland, established key partnerships, and developed a diverse product portfolio. He has focused on building a vertically integrated business model, from cultivation to finished products. His strategic decisions have positioned the company for growth in the evolving medical cannabis market. He has overseen the development of new cannabis-based pharmaceutical and cosmetic products.
MCCNF OTC Market Information
The OTC Other tier, where MCCNF trades, represents the lowest tier of the OTC market. Companies in this tier often have limited or no financial disclosure, making it difficult for investors to assess their financial health and operational performance. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies do not have to meet minimum listing standards, such as requirements for market capitalization, share price, or financial reporting. This lack of regulation increases the risk associated with investing in these companies.
- OTC Tier: OTC Other
- Limited financial disclosure.
- Low liquidity.
- High price volatility.
- Potential for fraud or manipulation.
- Lack of regulatory oversight.
- Verify the company's registration and legal standing.
- Attempt to obtain audited financial statements.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before investing.
- Operations in regulated markets (Colombia and Switzerland).
- Focus on medical cannabis and pharmaceutical applications.
- Presence of a CEO and management team.
- Development of a product portfolio.
- Efforts to establish partnerships.
What Investors Ask About Medcolcanna Organics Inc. (MCCNF) — Healthcare
What does the AI Score mean for MCCNF?
MCCNF holds an AI Score of 44/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Medcolcanna Organics Inc. is a medical cannabis company operating in Colombia and Switzerland. They cultivate, produce, and distribute medicinal cannabis and cannabis-derived products, including …
What does Medcolcanna Organics Inc. do?
Medcolcanna Organics Inc. operates as a medical cannabis company, focusing on the cultivation, production, and distribution of medicinal cannabis and cannabis-derived products. The company's operations are primarily based in Colombia and Switzerland, where it cultivates cannabis and manufactures a range of products, including pharmaceutical formulations, cosmetic products, and bulk Active Pharmaceutical Ingredients (APIs).
What do analysts say about MCCNF stock?
As of March 18, 2026, there is no readily available analyst consensus on MCCNF stock. Given the company's OTC listing and limited financial disclosure, it is difficult to obtain comprehensive analyst coverage. Investors should conduct their own thorough research and due diligence before making any investment decisions.
What are the main risks for MCCNF?
Medcolcanna Organics Inc. faces several risks inherent to the medical cannabis industry and its specific business operations. These include evolving regulations, which could restrict market access and increase compliance costs. Intense competition from established players and larger companies poses a threat to market share. Price volatility in the cannabis market can impact revenue and profitability.
What are the key factors to evaluate for MCCNF?
Medcolcanna Organics Inc. (MCCNF) holds an AI score of 44/100 (low). presents a high-risk, high-reward investment opportunity within the burgeoning medical cannabis market. Not financial advice.
How frequently does MCCNF data refresh on this page?
MCCNF's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven MCCNF's recent stock price performance?
Medcolcanna Organics Inc. (MCCNF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Operations in Colombia and Switzerland. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MCCNF overvalued or undervalued right now?
Medcolcanna Organics Inc. (MCCNF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research MCCNF before investing?
Before investing in Medcolcanna Organics Inc. (MCCNF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available for comprehensive analysis.
- OTC listing increases investment risk.
- Analyst coverage is limited.